Nobel Award Honors Groundbreaking Body's Defenses Discoveries

This year's prestigious award in medical science has been granted for transformative findings that clarify how the body's defense network targets dangerous pathogens while sparing the body's own cells.

Three renowned researchers—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research uncovered specialized "security guards" within the defense system that eliminate rogue immune cells capable of attacking the body.

These findings are now enabling new treatments for autoimmune diseases and cancer.

These winners will divide a monetary award valued at 11m SEK.

Crucial Findings

"Their work has been decisive for understanding how the body's defenses operates and why we do not all suffer from serious autoimmune diseases," commented the chair of the Nobel Committee.

The team's studies explain a core question: How does the immune system defend us from countless invaders while keeping our own tissues intact?

Our body's protection system uses white blood cells that search for signs of disease, even viruses and bacteria it has not met before.

Such cells utilize detectors—called recognition units—that are produced randomly in a vast number of combinations.

That gives the immune system the capacity to combat a broad range of invaders, but the randomness of the process unavoidably creates immune cells that can target the body.

Security Guards of the Body

Researchers earlier understood that a portion of these problematic defense cells were destroyed in the thymus—where white blood cells mature.

This year's award honors the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to disarm any defenders that assault the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "The discoveries have laid the foundation for a novel area of investigation and accelerated the development of new therapies, for instance for cancer and autoimmune diseases."

In cancer, T-regs block the system from attacking the growth, so research are aimed at reducing their quantity.

In self-attack disorders, trials are testing boosting regulatory T-cells so the body is not under attack. A comparable approach could also be effective in reducing the chances of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, of a Japanese institution, performed tests on mice that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from healthy mice could prevent the illness—suggesting there was a mechanism for preventing defenders from harming the host.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in mice and people that resulted in the discovery of a genetic factor critical for the way T-regs function.

"The pioneering work has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the body's own tissues," said a leading physiology expert.

"This work is a remarkable illustration of how fundamental physiological research can have broad implications for public health."